Catalog

Catalog is a synthetic biology company that has developed a proprietary platform for DNA-based data storage, positioning itself at the intersection of biotechnology and information technology. Its core innovation involves translating binary data into synthetic DNA strands, which are stored in specialized 'DNA Cards' and rack-mounted servers, offering unprecedented data density and longevity. The company's assets were acquired by Biomemory, which is now advancing the technology toward commercialization, targeting the massive and growing cold storage market. Catalog's vision extends beyond storage to a future of molecular information systems capable of search and computation.

Proprietary end-to-end platform for encoding digital data into synthetic DNA, storing it in specialized DNA Cards, and retrieving it via sequencing. Includes a rack-mounted server appliance designed for data center integration.

The DNA data storage field includes other biotech startups (e.g., Iridia) and significant R&D programs within large tech companies like Microsoft and Google. Competition also comes from ongoing improvements in incumbent technologies like magnetic tape and optical storage, which continue to evolve in density and cost.